摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-{4-[(2-甲氧基乙基)氨基]-1-哌啶基}乙酮 | 849021-41-6

中文名称
1-{4-[(2-甲氧基乙基)氨基]-1-哌啶基}乙酮
中文别名
——
英文名称
1-Acetyl-4-[(2-methoxyethyl)amino]piperidine
英文别名
1-[4-(2-methoxyethylamino)piperidin-1-yl]ethanone
1-{4-[(2-甲氧基乙基)氨基]-1-哌啶基}乙酮化学式
CAS
849021-41-6
化学式
C10H20N2O2
mdl
MFCD03452783
分子量
200.28
InChiKey
RMJGIXARLGOLGM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    92~97℃/0.1mm

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    41.6
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933399090

文献信息

  • TRICYCLIC FURAN-SUBSTITUTED PIPERIDINEDIONE COMPOUND
    申请人:Medshine Discovery Inc.
    公开号:EP3848371A1
    公开(公告)日:2021-07-14
    Disclosed are a series of tricyclic furan-substituted piperidinedione compounds and an application thereof in preparing a drug for treating a disease related to CRBN protein. In particular, disclosed is a derivative compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    公开了一系列三环呋喃取代的哌啶二酮化合物及其在制备治疗与 CRBN 蛋白质有关的疾病的药物中的应用。特别是公开了由式(I)代表的衍生物化合物或其药学上可接受的盐。
  • TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS
    申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    公开号:EP3848367A1
    公开(公告)日:2021-07-14
    The present invention discloses a series of tricyclic compounds and use thereof in preparing a medicament for treating a disease related to CRBN protein. Specifically, the present invention discloses a derivative compound of formula (1) or a pharmaceutically acceptable salt thereof.
    本发明公开了一系列三环化合物及其在制备治疗 CRBN 蛋白相关疾病的药物中的用途。具体而言,本发明公开了一种式(1)的衍生物化合物或其药学上可接受的盐。
  • Tricyclic furan-substituted piperidinedione compound
    申请人:MEDSHINE DISCOVERY INC.
    公开号:US11319330B2
    公开(公告)日:2022-05-03
    Disclosed are a series of tricyclic furan-substituted piperidinedione compounds and an application thereof in preparing a drug for treating a disease related to CRBN protein. In particular, disclosed is a derivative compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    公开了一系列三环呋喃取代的哌啶二酮化合物及其在制备治疗与 CRBN 蛋白质有关的疾病的药物中的应用。特别是公开了由式(I)代表的衍生物化合物或其药学上可接受的盐。
  • TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND
    申请人:MEDSHINE DISCOVERY INC.
    公开号:US20210317109A1
    公开(公告)日:2021-10-14
    Disclosed is a series of tricyclic substituted piperidine dione compounds, and applications thereof in the preparation of medicines for treating diseases related to CRBN protein; specifically disclosed are the derivative compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
查看更多